MicroX Labs Inc, founded in 2019, is a dynamic player in the Biotechnology and Health Care industries. Headquartered in the United States, the company is at the forefront of innovation in single cell analysis and flow cytometry.
Their platform features a unique disposable cartridge system, primarily utilized as a cartridge-based flow cytometer. This versatile platform can be adapted for any application that requires precise cell counting and classification, offering an advanced solution in point-of-care diagnostics.
The company secured a $275.00K Pre Seed Round investment on 02 March 2022, which provides critical support for further development of their technology. Despite the absence of publicly listed investors for this round, the investment reflects confidence in MicroX Labs Inc's potential to disrupt traditional models of cell analysis.
As MicroX Labs Inc continues to harness the potential of MEMS technology, it is poised for growth in the increasingly competitive market of cell analysis solutions.